Study Backs Hepatitis C Treatment in Injection Drug Users

Use of sofosbuvir-velpatasvir to treat hepatitis C virus (HCV) infection in injection drug users usually leads to a sustained virologic response at 12 weeks...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news